In Silico Investigations of the Anti-Catabolic Effects of Pamidronate and Denosumab on Multiple Myeloma-Induced Bone Disease [PDF]
PLoS ONE, 2012 It is unclear whether the new anti-catabolic agent denosumab represents a viable alternative to the widely used anti-catabolic agent pamidronate in the treatment of Multiple Myeloma (MM)-induced bone disease. This lack of clarity primarily stems from the
Yan Wang, Bo Lin
openalex +3 more sources
Remarkable response of juvenile diffuse sclerosing osteomyelitis of mandible to pamidronate. [PDF]
, 2007 We report a juvenile case of diffuse sclerosing osteomyelitis of the mandible that showed a favorable response to pamidronate, a bisphosphonate derivative.
Ishikawa, Makoto +5 more
core +3 more sources
Extensive protein expression changes induced by pamidronate in RAW 264.7 cells as determined by IP-HPLC [PDF]
PeerJ, 2020 Background: Bisphosphonate therapy has become a popular treatment for osteoporosis, Paget's disease, multiple myeloma, osteogenesis imperfecta, myocardial infarction, and cancer despite its serious side effects.
Lee, Suk Keun +3 more
core +3 more sources
Use of pamidronate for osteoporosis treatment in public health care in Brazil
Revista Brasileira de Reumatologia, 2016 Purpose: The use of bisphosphonates for osteoporosis is effective in reducing the risk of fractures. However, oral formulations are sometimes not well tolerated or are contraindicated.
Leila Bianchet Zanatta +5 more
openalex +3 more sources
Intravenous Pamidronate Therapy in Taiwanese Patients with Osteogenesis Imperfecta
Pediatrics and Neonatology, 2008 BackgroundInformation on the long-term efficacy of intravenous pamidronate therapy in Asian patients with osteogenesis imperfecta (OI) is limited. We report our experience using pamidronate in Taiwanese patients with OI.MethodsTwenty-six patients with ...
Lin, Hsiang-Yu +9 more
core +2 more sources
Comparison of Calcitonin and Pamidronate Treatments in Children with Osteogenesis Imperfecta
Çukurova Üniversitesi Tıp Fakültesi Dergisi, 2013 Purpose: The main objective of this study was to compare the treatments of calcitonin and pamidronate by clinical, biochemical, and radiological findings in children with osteogenesis imperfecta and evaluate the efficiency of pamidronate treatment ...
Eda Mengen +5 more
core +1 more source
Intravenous pamidronate for refractory rheumatoid arthritis
Journal of Research in Medical Sciences, 2012 Background: Patients with rheumatoid arthritis may be resistant to conventional treatment with disease-modifying antirheumatic drugs (DMARDs). On the other hand, biologic therapy is costly and may be inconvenient for many patients.
Ziba Farajzadegan +3 more
core +1 more source
Pamidronate infusion improved two cases of intractable seronegative rheumatoid arthritise
Journal of Research in Medical Sciences, 2011 Pamidronate is a bisphosphonate derivative that can inhibit bone resorption by actions on osteoclasts and increase bone density in spite of treatment with steroids. This drug has the anti-inflammatory effect by increase apoptosis of monocytes.
Peyman Mottaghi, Mansour Salesi
core +1 more source
Brazilian Journal of Medical and Biological Research, 2012 Osteoporosis is a major complication of chronic cholestatic liver disease (CCLD). We evaluated the efficacy of using disodium pamidronate (1.0 mg/kg body weight) for the prevention (Pr) or treatment (Tr) of cholestasis-induced osteoporosis in male Wistar
Facincani, I. +15 more
core +3 more sources
Safe and tolerable one-hour pamidronate infusion for multiple myeloma patients
Therapeutics and Clinical Risk Management, 2008 Dimitrios Chantzichristos, Andréasson Björn, Johansson PeterDepartment of Internal Medicine, Uddevalla Hospital, Uddevalla, SwedenBackground: Once a month, patients with multiple myeloma received an infusion of bisphosphonates ...
Andréasson Björn +2 more
core +1 more source